Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2019; 40(02): 147-158
DOI: 10.1055/s-0039-1684029
DOI: 10.1055/s-0039-1684029
Review Article
Histology of Pulmonary and Bronchiolar Disorders in Connective Tissue Diseases
Further Information
Publication History
Publication Date:
28 May 2019 (online)
Abstract
Connective tissue diseases (CTDs) are a heterogeneous group of disorders, acquired or hereditary, involving an autoimmune-mediated inflammation of connective tissues in the whole body. Lung involvement is common with CTDs, and associated with significant morbidity and mortality. Each compartment of the lung may be affected, often simultaneously, depending on the type of CTD. In addition, the lung may show pathological changes related to treatment, such as infection, drug reaction, and neoplasia. A multidisciplinary approach to diagnose these patients is essential and incorporates radiological and clinical as well as pathological data. In this review we describe the patterns of lung disease associated with common CTDs, lung disease in pediatric CTD patients, and newly recognized conditions.
-
References
- 1 Bonafede RP, Benatar SR. Bronchocentric granulomatosis and rheumatoid arthritis. Br J Dis Chest 1987; 81 (02) 197-201
- 2 Lynch III JP, Weigt SS, DerHovanessian A, Fishbein MC, Gutierrez A, Belperio JA. Obliterative (constrictive) bronchiolitis. Semin Respir Crit Care Med 2012; 33 (05) 509-532
- 3 Kreider M, Highland K. Pulmonary involvement in Sjögren syndrome. Semin Respir Crit Care Med 2014; 35 (02) 255-264
- 4 Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine 2014; 81 (02) 118-124
- 5 Vitale A, Sota J, Rigante D. , et al. Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives. Curr Rheumatol Rep 2016; 18 (01) 3
- 6 Travis WD, Costabel U, Hansell DM. , et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188 (06) 733-748
- 7 Kambouchner M, Levy P, Nicholson AG. , et al. Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology 2014; 65 (04) 549-560
- 8 Nunes H, Schubel K, Piver D. , et al. Nonspecific interstitial pneumonia: survival is influenced by the underlying cause. Eur Respir J 2015; 45 (03) 746-755
- 9 Tansey D, Wells AU, Colby TV. , et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44 (06) 585-596
- 10 Kono M, Nakamura Y, Enomoto N. , et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 2014; 9 (04) e94775
- 11 Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek ME. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med 2016; 114: 53-60
- 12 Sterclova M, Skibova J, Vasakova M. Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features. Eur Respir J 2017; 50 (suppl 61): PA867
- 13 Fischer A, Antoniou KM, Brown KK. , et al; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46 (04) 976-987
- 14 Adegunsoye A, Oldham JM, Valenzi E. , et al. Interstitial pneumonia with autoimmune features: value of histopathology. Arch Pathol Lab Med 2017; 141 (07) 960-969
- 15 Oldham JM, Adegunsoye A, Valenzi E. , et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016; 47 (06) 1767-1775
- 16 Ahmad K, Barba T, Gamondes D. , et al. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 2017; 123: 56-62
- 17 Ito Y, Arita M, Kumagai S. , et al. Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 2017; 17 (01) 111
- 18 Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med 2016; 119: 150-154
- 19 Kelly BT, Moua T. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology 2018; 23 (06) 600-605
- 20 Amitani R, Niimi A, Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu 1992; 11: 693-699
- 21 Frankel SK, Cool CD, Lynch DA, Brown KK. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126 (06) 2007-2013
- 22 Khiroya R, Macaluso C, Montero MA. , et al. Pleuroparenchymal fibroelastosis: a review of histopathologic features and the relationship between histologic parameters and survival. Am J Surg Pathol 2017; 41 (12) 1683-1689
- 23 Watanabe K. Pleuroparenchymal fibroelastosis: its clinical characteristics. Curr Respir Med Rev 2013; 9: 299-237
- 24 Petrie GR, Bloomfield P, Grant IW, Crompton GK. Upper lobe fibrosis and cavitation in rheumatoid disease. Br J Dis Chest 1980; 74 (03) 263-267
- 25 Enomoto Y, Nakamura Y, Colby TV. , et al. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One 2017; 12 (06) e0180283
- 26 Kinoshita Y, Watanabe K, Ishii H. , et al. Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases. Virchows Arch 2019; 474 (01) 97-104
- 27 Aithala R, Alex AG, Danda D. Pulmonary hypertension in connective tissue diseases: an update. Int J Rheum Dis 2017; 20 (01) 5-24
- 28 Lv TT, Wang P, Guan SY. , et al. Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis. Ir J Med Sci 2018; 187 (03) 723-730
- 29 Huang D, Cheng YY, Chan PH. , et al. Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study. ERJ Open Res 2018 ;4(1) Doi: 10.1183/23120541.00135-2017
- 30 Badesch DB, Abman SH, Ahearn GS. , et al; American College of Chest Physicians. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1, Suppl): 35S-62S
- 31 Shahane A. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis. Rheumatol Int 2013; 33 (07) 1655-1667
- 32 Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978; 64 (06) 998-1004
- 33 Mittoo S, Fell CD. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 2014; 35 (02) 249-254
- 34 Ta R, Celli R, West AB. Diffuse alveolar hemorrhage in systemic lupus erythematosus: histopathologic features and clinical correlations. Case Rep Pathol 2017; 2017: 1936282
- 35 Young ID, Ford SE, Ford PM. The association of pulmonary hypertension with rheumatoid arthritis. J Rheumatol 1989; 16 (09) 1266-1269
- 36 Price TM, Skelton MO. Rheumatoid arthritis with lung lesions. Thorax 1956; 11 (03) 234-240
- 37 Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev 2015; 24 (135) 1-16
- 38 Zhang L, Visscher D, Rihal C, Aubry MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007; 27 (12) 1163-1165
- 39 O'Callaghan DS, Dorfmuller P, Jaïs X. , et al. Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?. Presse Med 2011; 40 (1, Pt 2): e65-e78
- 40 Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in behcet disease: a cumulative analysis. Chest 2005; 127 (06) 2243-2253
- 41 Slavin RE, de Groot WJ. Pathology of the lung in Behçet's disease. Case report and review of the literature. Am J Surg Pathol 1981; 5 (08) 779-788
- 42 Lally L, Spiera RF. Pulmonary vasculitis. Rheum Dis Clin North Am 2015; 41 (02) 315-331
- 43 Vivero M, Padera RF. Histopathology of lung disease in the connective tissue diseases. Rheum Dis Clin North Am 2015; 41 (02) 197-211
- 44 Primack SL, Miller RR, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. AJR Am J Roentgenol 1995; 164 (02) 295-300
- 45 Carmier D, Diot E, Diot P. Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy. Expert Rev Respir Med 2011; 5 (01) 33-39
- 46 Borrell H, Narváez J, Alegre JJ. , et al. Shrinking lung syndrome in systemic lupus erythematosus: a case series and review of the literature. Medicine (Baltimore) 2016; 95 (33) e4626
- 47 Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB. Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus 2018; 27 (03) 365-371
- 48 Tavoni A, Vitali C, Cirigliano G, Frigelli S, Stampacchia G, Bombardieri S. Shrinking lung in primary Sjögren's syndrome. Arthritis Rheum 1999; 42 (10) 2249-2250
- 49 Scirè CA, Caporali R, Zanierato M, Mojoli F, Braschi A, Montecucco C. Shrinking lung syndrome in systemic sclerosis. Arthritis Rheum 2003; 48 (10) 2999-3000
- 50 Rider LG, Shah M, Mamyrova G. , et al; Childhood Myositis Heterogeneity Collaborative Study Group. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92 (04) 223-243
- 51 Tansley SL, Betteridge ZE, Gunawardena H. , et al; UK Juvenile Dermatomyositis Research Group. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 2014; 16 (04) R138
- 52 Dell S, Cernelc-Kohan M, Hagood JS. Diffuse and interstitial lung disease and childhood rheumatologic disorders. Curr Opin Rheumatol 2012; 24 (05) 530-540
- 53 Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009; 33 (04) 882-896
- 54 Schneider F, Gruden J, Tazelaar HD, Leslie KO. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 2012; 136 (10) 1242-1252
- 55 Cidon M, Bansal M, Hartl D. Pulmonary manifestations of rheumatologic diseases. Curr Opin Pediatr 2017; 29 (03) 311-319
- 56 Richardson AE, Warrier K, Vyas H. Respiratory complications of the rheumatological diseases in childhood. Arch Dis Child 2016; 101 (08) 752-758
- 57 Corrin B, Nicholson AG. Pathology of the Lungs. Pulmonary manifestations of systemic disease. 3rd edition. Churchill Livingstone: Elsvier; 2011. pp. 472